Literature DB >> 3912692

[Surgical tumor reduction in extensive ovarian cancer].

H Pickel, H Stettner, M Lahousen.   

Abstract

The value of radical resected residual tumors and the involvement of the lymph nodes are discussed on a series of 206 patients with ovarian carcinoma. The following results were achieved: macroscopically no tumor 100 patients; residual tumors smaller than 2 cm 14 patients, residual tumors larger than 3 cm 92 patients. Different chemotherapies were also applied. The survival rate of these groups after 2 years was as follows: 80.5%, 85.7%, 38.6%. After 5 years: 58.7%, 0%, 13.1%. In 48 patients after radical surgery and lymphadenectomy who had no post-operative residual tumors the survival rate was 100%, depending on the involvement of the lymph nodes.

Entities:  

Mesh:

Year:  1985        PMID: 3912692     DOI: 10.1159/000215686

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  2 in total

1.  Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer.

Authors:  W Jäger; R Adam; L Wildt; N Lang
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

2.  [Surgical therapy of ovarian cancer].

Authors:  A Pfleiderer
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.